LMFM By Michael Carolan The company has announced it's to build a new manufacturing facility at the company’s newly acquired Dunboyne Biologics campus. MSD has announced it's to build a new manufacturing facility at the company’s newly acquired Dunboyne Biologics campus. The new facility is expected to create an estimated 140 new jobs by 2025. Additionally, the existing MSD Dunboyne Biologics facility expect to hire approximately 100 new employees within the coming year. MSD says co-locating this new facility beside an existing plant will support greater innovation and collaboration between MSD’s research and manufacturing teams, which will significantly accelerate the time it takes to bring a medicine to market benefiting patients world-wide.